Keyphrases
Murine Cells
100%
Therapy Development
100%
Sarcomatoid Hepatocellular Carcinoma
100%
Glucose-6-phosphate Dehydrogenase (G6PD)
66%
Tumor
33%
Vimentin
33%
CD133
33%
Poor Survival
33%
Hepatocellular Carcinoma Cells
33%
Microarray Analysis
16%
Supernatant
16%
Migration Rate
16%
N-cadherin
16%
Novel Therapies
16%
Liver
16%
Mouse Liver
16%
Sphere Formation
16%
Side Population
16%
Potential Biomarkers
16%
High-level Expression
16%
Proteomic Analysis
16%
Positive Staining
16%
Novel Biomarkers
16%
Plasma Proteins
16%
Biomarkers Therapeutic Target
16%
Liver Cancer Cell Lines
16%
CD133 Expression
16%
Pentose Phosphate Pathway
16%
Human Specimen
16%
HCC Cells
16%
Sarcomatous
16%
Rare Type
16%
Biomarker Development
16%
EMT Markers
16%
Allograft Tumors
16%
Hepa1-6
16%
Medicine and Dentistry
Cell Line
100%
Biological Marker
100%
Hepatocellular Carcinoma
100%
Therapy Development
100%
Sarcomatoid
100%
Neoplasm
50%
Vimentin
33%
Glucose 6 Phosphate Dehydrogenase
33%
Microarray Analysis
16%
Carcinoma Cell
16%
Allograft
16%
Serum Total Protein
16%
Nerve Cell Adhesion Molecule
16%
Proteomics
16%
Epithelial Mesenchymal Transition
16%
Liver Cancer Cell Line
16%
Hepatocellular Carcinoma Cell Line
16%
Pentose Phosphate Cycle
16%
Side Population
16%
Human Specimen
16%
Biochemistry, Genetics and Molecular Biology
CD133
100%
Vimentin
66%
Glucose-6-Phosphate Dehydrogenase
66%
Microarrays
33%
Cancer Cell
33%
Proteomics
33%
Enzyme
33%
Neural Cell Adhesion Molecule
33%
Side Population
33%
Serum Total Protein
33%
Hexose Monophosphate Shunt
33%
Immunology and Microbiology
Cell Line
100%
Blood Plasma
50%
Neural Cell Adhesion Molecule
50%
Carcinoma Cell
50%
Hepatocellular Carcinoma Cell Line
50%
Pentose Phosphate Cycle
50%
Liver Cancer Cell Line
50%
Allograft
50%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Biological Marker
100%
Neoplasm
50%
Vimentin
33%
Glucose 6 Phosphate Dehydrogenase
33%
Plasma Protein
16%
Nerve Cell Adhesion Molecule
16%
Liver Cancer
16%
Pentose Phosphate
16%